@FierceMedDev: Endo's AMS owes $54.5M in vaginal mesh lawsuit. News | Follow @FierceMedDev
@DamianFierce: Philips' is enduring its third ventilator recall in about a year, drawing a deadly FDA warning. Report | Follow @DamianFierce
@MichaelGFierce: Biosensor nanoparticles deliver cancer drug with precise, 3-D imaging. FierceDrugDelivery story | Follow @MichaelGFierce
> Johnson & Johnson ($JNJ) is launching satellite offices around the globe to hunt for deals. Report
> ALung Technologies has raised $9.5 million to support its Hemolung respiratory assist system. Article
> NeuroSigma is launching its depression-treating Monarch eTNS device in Canada. More
> IncellDx has signed on with India's GeneCell Diagnostics to offer its HPV test in the country's growing market. Story (reg. req.)
> Sway Medical has emerged from stealth and raised $750,000 to support its FDA-cleared concussion-management app. News
Biotech News
@FierceBiotech: ICYMI: 10 startups fueling pharma in social media. Special report | Follow @FierceBiotech
@JohnCFierce: Under review and well past Ph3: Can Novartis gain anything from its latest breakthrough drug win at the FDA? Article | Follow @JohnCFierce
@RyanMFierce: The news: Ablynx heads to PhI w/ German Merck. The takeaway: Misspell Merck Serono, and it rhymes with 'My Sharona." Story | Follow @RyanMFierce
@EmilyMFierce: New at FierceBiotechResearch.com: Penn scientists create human-cell model of pancreatic cancer. Story | Follow @EmilyMFierce
> J&J spreads deal-making net with global ring of satellite offices. More
> Takeda asks FDA to OK its potential inflammatory bowel disease blockbuster. News
> Idenix plunges after FDA throws up a roadblock for lead hep C 'nuc.' Report
Pharma News
@FiercePharma: Needy Forest Labs reportedly eyes a bid for Elan. But why? Yesterday's story | Follow @FiercePharma
@EricPFierce: Who manufactures the top selling diabetes treatments? Novo has 5 of top 10, but not the top two. Special report | Follow @EricPFierce
> Pfizer's Viagra patent in Europe expires today. Article
> Teva's one-pill 'morning after' drug allowed OTC. Story
> Bristol-Myers Squibb gets a boost for leukemia drug Sprycel. Report